Watcharee Pagornrat
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
Journal: The Lancet. Infectious diseases
Published: April 02, 2025
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV).
Journal: The Lancet. Infectious diseases
Published: January 15, 2024
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
Journal: The Lancet. Infectious diseases
Published: June 12, 2023
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).
Journal: The Journal of infectious diseases
Published: February 20, 2023
Genetic population of Plasmodium knowlesi during pre-malaria elimination in Thailand.
Journal: Malaria journal
Published: July 01, 2021
Polymorphic markers for identification of parasite population in Plasmodium malariae.
Journal: Malaria journal
Published: November 20, 2019
The first Plasmodium vivax relapses of life are usually genetically homologous.
Journal: The Journal of infectious diseases
Published: December 24, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026